» Articles » PMID: 36932241

Diagnostic Classification of Childhood Cancer Using Multiscale Transcriptomics

Abstract

The causes of pediatric cancers' distinctiveness compared to adult-onset tumors of the same type are not completely clear and not fully explained by their genomes. In this study, we used an optimized multilevel RNA clustering approach to derive molecular definitions for most childhood cancers. Applying this method to 13,313 transcriptomes, we constructed a pediatric cancer atlas to explore age-associated changes. Tumor entities were sometimes unexpectedly grouped due to common lineages, drivers or stemness profiles. Some established entities were divided into subgroups that predicted outcome better than current diagnostic approaches. These definitions account for inter-tumoral and intra-tumoral heterogeneity and have the potential of enabling reproducible, quantifiable diagnostics. As a whole, childhood tumors had more transcriptional diversity than adult tumors, maintaining greater expression flexibility. To apply these insights, we designed an ensemble convolutional neural network classifier. We show that this tool was able to match or clarify the diagnosis for 85% of childhood tumors in a prospective cohort. If further validated, this framework could be extended to derive molecular definitions for all cancer types.

Citing Articles

Integrated Whole Genome and Transcriptome Sequencing as a Framework for Pediatric and Adolescent AML Diagnosis and Risk Assessment.

Wang L, Voss R, Pastor V, Cardenas M, Kumar P, Maciaszek J Res Sq. 2025; .

PMID: 39975890 PMC: 11838756. DOI: 10.21203/rs.3.rs-5775959/v1.


Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck.

Luo J, Bishop J, Dubois S, Hanna G, Sholl L, Stelow E Nat Rev Clin Oncol. 2025; .

PMID: 39900969 DOI: 10.1038/s41571-025-00986-3.


M&M: an RNA-seq based pan-cancer classifier for paediatric tumours.

Wallis F, Baker-Hernandez J, van Tuil M, van Hamersveld C, Koudijs M, Verwiel E EBioMedicine. 2024; 111:105506.

PMID: 39709770 PMC: 11784659. DOI: 10.1016/j.ebiom.2024.105506.


When Do Tumours Develop? Neoplastic Processes Across Different Timescales: Age, Season and Round the Circadian Clock.

Bieuville M, Dujon A, Raven N, Ujvari B, Pujol P, Eslami-S Z Evol Appl. 2024; 17(10):e70024.

PMID: 39444444 PMC: 11496201. DOI: 10.1111/eva.70024.


The Prevalence of Cancer Predisposition Syndromes (CPSs) in Children with a Neoplasm: A Cohort Study in a Central and Eastern European Population.

Telman-Kolodziejczyk G, Strauss E, Sosnowska-Sienkiewicz P, Januszkiewicz-Lewandowska D Genes (Basel). 2024; 15(9).

PMID: 39336731 PMC: 11431396. DOI: 10.3390/genes15091141.


References
1.
Lam C, Howard S, Bouffet E, Pritchard-Jones K . Science and health for all children with cancer. Science. 2019; 363(6432):1182-1186. DOI: 10.1126/science.aaw4892. View

2.
Miller R, Young Jr J, Novakovic B . Childhood cancer. Cancer. 1995; 75(1 Suppl):395-405. DOI: 10.1002/1097-0142(19950101)75:1+<395::aid-cncr2820751321>3.0.co;2-w. View

3.
Kattner P, Strobel H, Khoshnevis N, Grunert M, Bartholomae S, Pruss M . Compare and contrast: pediatric cancer versus adult malignancies. Cancer Metastasis Rev. 2019; 38(4):673-682. DOI: 10.1007/s10555-019-09836-y. View

4.
Janeway K, Place A, Kieran M, Harris M . Future of clinical genomics in pediatric oncology. J Clin Oncol. 2013; 31(15):1893-903. DOI: 10.1200/JCO.2012.46.8470. View

5.
Filbin M, Monje M . Developmental origins and emerging therapeutic opportunities for childhood cancer. Nat Med. 2019; 25(3):367-376. PMC: 6631320. DOI: 10.1038/s41591-019-0383-9. View